Sight Sciences: Jeremy Hayden plans $70.1K share sale
The stated sale includes an amount necessary to cover a tax obligation resulting from settlement of a vested equity award distribution.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Sight Sciences, Inc. (SGHT) officer Jeremy B. Hayden reported a planned sale of 12,733 common shares, with an aggregate market value of $70,132.10 and an approximate sale date of July 6, 2026. Hayden acquired 12,733 shares through restricted stock vesting on June 30, 2026. Joshua Schmitt signed as a duly authorized representative of Fidelity Brokerage Services LLC and attorney-in-fact for Jeremy Hayden.
Key Figures
Key Terms
Restricted Stock Vesting financial
Aggregate Market Value financial
vested equity award distribution financial
attorney-in-fact regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What previous SGHT sale did Jeremy Hayden report?
AI-generated analysis. How Rhea-AI works. Not financial advice.